Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Comparison of 2 commercial antibody ELISA kits for identification of high proviral load carrier cattle in strategic control of bovine leukemia virus infection.

Created on 13 Aug 2026

Authors

Takenori Arai, Saki Uehara, Sonoko Kondo, Takehisa Yamamoto, Tomomi Kanazawa, Aiko Yamamoto-Kinami, Kei-Ichi Matsuda, Takashi Matsuzaki, Shinji Yamada, Hirokazu Hikono, Kenji Murakami

Published in

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc. Pages 10406387261466243. Aug 13, 2026. Epub Aug 13, 2026.

Abstract

Bovine leukemia virus (BLV; family Retroviridae, taxon species Deltaretrovirus bovleu) infection poses a serious threat to cattle health, and the strategic identification of high proviral-load (PVL) carriers is essential for disease control. We evaluated 2 commercial ELISA kits for the detection of BLV antibodies and indirect identification of high-PVL cattle (EBL ELISA [Nippon Gene] and Leukosis Serum X2 [Idexx]) using a cross-sectional survey of 155 cattle from 17 farms. Based on our quantitative real-time PCR (qPCR) results, we classified tested cattle into non-infected, low-PVL (<400 copies/10 ng DNA), and high-PVL (≥400 copies/10 ng DNA) groups. The 2 ELISA kits had excellent agreement (κ = 0.97; 95% CI [0.93, 1.00]) and moderate correlation (r = 0.617). In a receiver operating characteristic curve analysis, the Leukosis Serum X2 ELISA performed better than the EBL ELISA at identifying high-PVL cattle, with a higher area under the curve (0.840 vs. 0.785) and higher sensitivity (89.7% vs. 84.6%) and specificity (66.4% vs. 56.9%). Both ELISA kits had a moderate ability to distinguish high-level BLV-infected cattle. Our results suggest that a 2-step screening concept could be valuable: ELISA screening followed by confirmatory qPCR testing to identify cattle with a high PVL.

PMID:
42591061
Bibliographic data and abstract were imported from PubMed on 13 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement